Neuropsychiatric Disorders in Parkinson’s Disease

Authors

  • M.M.Raimova Associate Professor, Doctor of Medical Science Tashkent State Dental Institute Tashkent, Uzbekistan
  • S.A. Alikhanov Neuropathologist Tashkent State Dental Institute Tashkent, Uzbekistan

Keywords:

neuropsychic disorder, sensory disorder, autonomic disorder,, depression, dementia, patients, fatigue,, significant correlation, dynamics of indicators, independent genesis

Abstract

This article discusses neuropsychiatric disorders in Parkinson’s disease. We have demonstrated high efficiency in relation to fatigue in PD ADR Mirapex. So, if before therapy a pronounced degree of fatigue according to the corresponding scale for assessing fatigue was noted in 64% of patients, then after treatment - only in 26%. It is important that no significant correlation was found between the dynamics of indicators of fatigue and motor functions, depression, sleep disorders during therapy, which indirectly indicates independent genesis of this symptom and specificity the Mirapex effect.

Downloads

Download data is not yet available.

References

Noe-Sebastian, E., Irimia-Sieira, P., Pomares-Arias, E., Martinez-Vila, E., & Luquin-Piudo, M. R. (2001). Neuropsychiatric disorders in Parkinson's disease. Revista de neurologia, 32(7), 676-681.

Dujardin, K., & Sgambato, V. (2020). Neuropsychiatric disorders in parkinson’s disease: what do we know about the role of dopaminergic and non-dopaminergic systems?. Frontiers in neuroscience, 14, 25.

Lang, A. E., & Lozano, A. M. (1998). Parkinson's disease. New England Journal of Medicine, 339(16), 1130-1143.

Dauer, W., & Przedborski, S. (2003). Parkinson's disease: mechanisms and models. Neuron, 39(6), 889-909.

De Lau, L. M., & Breteler, M. M. (2006). Epidemiology of Parkinson's disease. The Lancet Neurology, 5(6), 525-535.

Jankovic, J. (2008). Parkinson’s disease: clinical features and diagnosis. Journal of neurology, neurosurgery & psychiatry, 79(4), 368-376.

Cummings, J. L. (1992). Depression and Parkinson's disease: a review. The American journal of psychiatry.

Nussbaum, R. L., & Ellis, C. E. (2003). Alzheimer's disease and Parkinson's disease. New england journal of medicine, 348(14), 1356-1364.

Katzenschlager, R., Sampaio, C., Costa, J., & Lees, A. (2002). Anticholinergics for symptomatic management of Parkinson s disease. Cochrane Database of Systematic Reviews, (3).

Forno, L. S. (1988). The neuropathology of Parkinson’s disease. Progress in Parkinson Research, 11-21.

Calne, D. B., Snow, B. J., & Lee, C. (1992). Criteria for diagnosing Parkinson's disease. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 32(S1), S125-S127.

Davie, C. A. (2008). A review of Parkinson's disease. British medical bulletin, 86(1), 109-127.

Downloads

Published

2021-11-18

How to Cite

M.M.Raimova, & S.A. Alikhanov. (2021). Neuropsychiatric Disorders in Parkinson’s Disease. International Scientific and Current Research Conferences, 1(01), 176–180. Retrieved from https://www.orientalpublication.com/index.php/iscrc/article/view/223

Issue

SCIENCE, EDUCATION, INNOVATION IN THE MODERN WORLD

Section

Articles

License

Copyright (c) 2021 M.M.Raimova, S.A. Alikhanov

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The content published on the International Scientific and Current Research Conferences platform, including conference papers, abstracts, and presentations, is made available under an open-access model. Users are free to access, share, and distribute this content, provided that proper attribution is given to the original authors and the source.